Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Assure Holdings Corp IONM

Assure Holdings Corp. is a provider of outsourced intraoperative neurophysiological monitoring (IONM) and remote neurology services. The Company delivers a suite of clinical and operational services to support surgeons and medical facilities during invasive procedures. Its IONM tool is used for various surgical verticals, such as neurosurgery, spine, ear, nose, and throat, and other surgical procedures. Its in-house interoperative neurophysiologists (INP) provide the technical component IONM services from the operating room throughout the procedure, while telehealth-oriented supervising practitioners provide a level of redundancy and risk mitigation in support of the onsite INPs and the surgical team. It offers IONM services, including scheduling the INP and supervising practitioner, real-time monitoring, patient advocacy and subsequent billing for services provided. During each procedure, it provides two types of services, the Technical Component and Professional Component of IONM.


NDAQ:IONM - Post by User

Bullboard Posts
Post by billy4325on Aug 07, 2018 11:44am
175 Views
Post# 28421357

2017 Financials Released

2017 Financials Released2017 financials statments are up on SEDAR.  A loss of $5.5 million for the year.  The largest expense is a "provision for performance share compensation" of $16 million.  From the MD&A:

Performance share compensation - The Company entered into stock grant agreements with two executives (Messrs. Parsons and Willer respectively) on November 8, 2016, each of which inter alia defines a bonus share threshold as follows: should the Company meet or exceed a 2017 fiscal year EBITDA threshold of $7,500,000 CAD, the Company would issue 6,000,000 Common Shares of the surviving issuer at the trailing 30-day average closing price. Mr. Parsons has agreed to modify his stock grant agreement to change the threshold from EBITDA to cash received to achieve the equivalent EBITDA threshold. The Company is engaged in discussions with Mr. Willer regarding his stock grant agreement and other matters. As the Company achieved the EDITDA threshold for the year ended December 31, 2017, the Company has recorded a liability equivalent to the value of the shares to be issued while the agreements are modified and the cash collected threshold is achieved, which the Company deems probable.


Bullboard Posts